drug prices | The Lund Report

Can California Beat The Federal Government In Lowering Drug Prices?

California Gov. Gavin Newsom says he’s done waiting for the federal government to curtail the rising cost of prescription drugs.

Newsom has his own plan to ease that financial burden — one he hopes other states can join or replicate.

By:

Samantha Young

Multiple Sclerosis Patients Face Skyrocketing Drug Costs, Study Finds

Medicare patients with multiple sclerosis face skyrocketing costs for treatment due to insurance regulations that force them to pay more out of pocket for generic drugs, a study has found.

By:

Alex Visser

Trump Adds Global Pricing Plan To Attack On Drug Prices

Experts welcomed the administration's plan to tackle Medicare Part B's soaring drug bill but questioned its approach.

President Donald Trump’s new pledge to crack down on “the global freeloading” in prescription drugs had a sense of déjà vu.

By:

Sarah Jane Tribble

Congress Bans Pharmacist ‘Gag Orders’ On Drug Prices

Pharmacists have been prevented from telling consumers when the cash price for a drug is lower than the cost through their insurer. But critics say this will not affect the causes of high drug prices.

For years, most pharmacists couldn’t give customers even a clue about an easy way to save money on prescription drugs. But the restraints are coming off.

By:

Susan Jaffe

Trump Administration Sinks Teeth Into Paring Down Drug Prices, On 5 Key Points

Officials are working on a multi-pronged plan to promote competition, attack the drug rebate system and introduce other ways to lower prices.

Three months after President Donald Trump announced his blueprint to bring down drug prices, administration officials have begun putting some teeth behind the rhetoric.

By:

Sarah Jane Tribble

Briefly: Sen. Wyden blasts Trump administration over drug pricing plan

The ranking Democrat on the U.S. Senate Finance Committee and Oregon senator called on the administration to release public comments on the plan.

Oregon U.S. Sen. Ron Wyden again blasted the Trump administration on Monday over its proposed drug pricing plan.

By:

Lynne Terry

Report: The Higher the Drug Prices, the More Industry Benefits

In the latest look at drug prices, a study released Tuesday shows that higher prices benefit key players involved in the distribution -- not the development -- of drugs. Consumers and Medicare foot the bill.

Insurance companies, investors and middlemen are making billions of dollars off prescription drugs – even when they don’t research, develop or make the pills themselves, according to a report out Tuesday from Democrats on the U.S.

By:

Courtney Sherwood

Nosse and Steiner Hayward Back Mandatory Rebates for High-Cost Drugs

The Oregon Department of Consumer and Business Services would step in if a drug exceeded $10,000 or had cost increases greater than 3.4 percent. State regulators would index a price according to what other countries have negotiated for the drugs. Consumers would also see a cap on costs that they pay out-of-pocket.

Rep. Rob Nosse, D-Portland, touted his aggressive and innovative approach to tackling uncontrolled pharmaceutical costs on Thursday, calling on Oregon to lead where Congress has failed and other state-based reforms have fallen short.

By:

Chris Gray

First, Do No Harm

Over the past year, some insurance companies have become increasingly aggressive in exploiting and creating loopholes that would effectively force thousands of chronic disease patients into Medicare prematurely

OPINION -- In recent months, Americans have seen growing evidence of failure within the Affordable Care Act.

By:

Scott Bruun

Drug Prices in America: ROI or RIP?

Drug prices are killing Americans and making fortunes for pharmaceutical executives.

OPINION -- Long over are the halcyon (not to be confused with Halcion®) days when Jonas Salk said of the polio vaccine, “There is no patent. Could you patent the sun?”

By:

Kris Alman